Here in the media centre you will find a range of resources including our latest and archived press releases, statements from our CEO, speeches and presentations, information on our social media policy, and our photo and video library.

GSK/Novartis transaction

GSK plc today announces a major 3-part inter-conditional transaction with Novartis AG involving its Consumer Healthcare, Vaccines and Oncology businesses.

Speeches & presentations

Find the latest and archived speeches and presentations from GSK’s senior executives.

Press releases

These press releases are intended for business journalists and analysts/investors.
24 July 2014

FDA approves Flonase allergy relief for sale over-the-counter in the United States

No. 1 prescribed allergy treatment ingredient1 to be available OTC

24 July 2014

GSK announces EU regulatory submission for malaria vaccine candidate RTS,S

GSK announced today that it has submitted a regulatory application to the European Medicines Agency (EMA) for its malaria vaccine candidate, RTS,S.

23 July 2014

Results announcement for the second quarter 2014

GSK delivers Q2 2014 turnover £5.6 billion (-4%) and core EPS 19.1p (-12%) on ex-divestment basis (both CER). Q2 dividend 19p (+6%).

Annual Report 2013

Download the 2013 Annual Report

Information for investors